NYSE: ENFNEnfusion Inc Stock
$9.90+0.01 (+0.1%)
Updated Nov 28, 2023
ENFN Price
$9.90
Fair Value Price
N/A
Market Cap
$1.26B
52 Week Low
$7.37
52 Week High
$12.32
P/E
123.75x
P/B
24.88x
P/S
4.67x
PEG
N/A
Dividend Yield
N/A
Revenue
$168.57M
Earnings
$5.90M
Gross Margin
67.2%
Operating Margin
4.06%
Profit Margin
3.5%
Debt to Equity
0.56
Operating Cash Flow
$27M
Beta
1.34
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ENFN Overview
Enfusion, Inc. provides SaaS solutions to the investment management industry in the U.S. and internationally. Its offerings enable investment managers to make investment decisions in real-time. Functionalites includes a Portfolio Management System, an Order and Execution Management System, an Accounting/General Ledger System, and the Enfusion Analytics System. Enfusion was incorporated in 2021 and is headquartered in Chicago, IL.
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ENFN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ENFN is poor value based on its earnings relative to its share price (123.75x), compared to the US market average (32.56x)
P/E vs Market Valuation
ENFN is poor value based on its earnings relative to its share price (123.75x), compared to the US Software - Application industry average (57.47x)
P/E vs Industry Valuation
ENFN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more ENFN due diligence checks available for Premium users.
Be the first to know about important ENFN news, forecast changes, insider trades & much more!
ENFN News
Valuation
ENFN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
123.75x
Industry
57.47x
Market
32.56x
ENFN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ENFN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
ENFN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
24.88x
Industry
6.03x
ENFN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ENFN's financial health
Profit margin
Revenue
$44.4M
Net Income
$1.8M
Profit Margin
4.1%
ENFN's Earnings (EBIT) of $6.84M... subscribe to Premium to read more.
Interest Coverage Financials
ENFN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$101.7M
Liabilities
$28.5M
Debt to equity
0.56
ENFN's short-term assets ($62.05M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ENFN's short-term assets ($62.05M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ENFN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$12.1M
Investing
-$2.6M
Financing
-$5.3M
ENFN's operating cash flow ($26.57M)... subscribe to Premium to read more.
Debt Coverage Financials
ENFN vs App Stocks
Enfusion Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.